Columbus, Ohio — According to state and local economic development sources Andelyn Biosciences plans to invest $100,000,000.00 to build out 185,000 square feet of new space in Columbus. The company plans to occupy the new space at 1250 Arthur E. Adams Dr. in Columbus, on or about May 1, 2022. According to the company website Many patients would not be able to complete their childhood without the life-changing therapies in development at Andelyn Biosciences. By manufacturing gene therapies for clients worldwide, Andelyn is providing cures and hope for families looking for a healthy future. Andelyn Biosciences was born out of Nationwide Children’s Hospital and continues to have a close relationship with its world-class Abigail Wexner Research Institute. Andelyn Biosciences is driven by our fundamental purpose, highly reliable quality and unparalleled expertise. Our innovative manufacturing capabilities are paired with our clients’ life-changing research. Therapies for incurable diseases and rare disorders are the result.

To learn more about Andelyn Biosciences, visit http://www.andelynbio.com/

Company Contact:
Mayo Pujols, Chief Executive Officer
https://www.linkedin.com/in/mayopujols/
844-228-2366

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved